Excerpts from analyst's report

Maybank Kim Eng analyst: John Cheong

RaymondAng t6.2016Dr Raymond Ang, Chief Operating Officer of Q&M Dental, presenting to analysts, fund managers and other investors last week. Photo by Cheng Kam Him.Third-largest deal in China could open doors to more
Q&M has proposed to buy a 33% stake in Shenzhen New Perfect Dental Research (SZNP) for SGD13.8m, with full payment in cash. SZNP operates 16 laboratories that make customised dental prostheses in 15 China cities and has c.650 lab technicians.

This is Q&M’s third-largest deal in China since it acquired a dental hospital group (Aoxin) and a dental supplies manufacturer (Qinhuangdao) in 2014. 

Aside from earnings accretion, SZNP’s wide network could help it sniff out more acquisitions. Maintain BUY & raise TP to SGD1.08, based on 42x FY17E EPS.


Q&M Dental
Share price: 
76 c

Could rerate on more China M&As & vertical drive
This deal marks an important milestone for Q&M, as it has not made any major acquisitions in China with sizeable profit guarantees since 2014. Its last four deals were all smaller, with a total profit guarantee of only SGD0.4m. SZNP will add >SGD1m in FY17 and boost China contributions from c.35% in 2016 to c.40% in 2017.

Also, the acquisition of a second large dental supplies company suggests a widening of its M&A net to include more supply companies that can fit into its vertical integration strategy. This suggests higher M&A momentum in future.

Earnings-accretive deal with strong safeguards
Based on the profit guarantee of SGD1.03m attached to Q&M's 33% stake, this deal is valued at 13.3x FY17 P/E vs Q&M’s 30.5x. The profit guarantee forms 6%/5% of FY16E/17E earnings. Management expects to close the deal in late-2016, but we expect early-2017 to allow for extra time. Safeguards are similar to previous deals. The vendors will guarantee the next 12 years’ profit with a 10% CAGR for the first 6 years. They will also sign a 12-year service agreement.

Raise TP to SGD1.08; Maintain BUY & top sector pick
We raise our TP to SGD1.08, up from SGD1.05, after raising our FY17-18E EPS by 4% to include earnings contributions from SZNP. TP is still based on 42x FY17E P/E, 1SD above its five-year mean to capture its M&A potential. Along with ISEC, Q&M is a top healthcare pick given its EPS growth potential and China healthcare exposure.

Full report here.

Share Prices

Counter NameLastChange
AEM Holdings1.0400.010
Alliance Mineral0.117-0.006
Anchor Resources0.014-0.001
Avi-Tech Electronics0.280-
Best World Int.1.360-
China Sunsine1.120-0.010
CSE Global0.485-
Food Empire0.500-
Geo Energy0.161-
Golden Energy0.200-0.010
GSS Energy0.082-
ISDN Holdings0.230-0.005
KSH Holdings0.420-0.005
Moya Asia0.075-0.001
Nordic Group0.300-
Oxley Holdings0.325-0.005
REX International0.068-0.001
Sing Holdings0.4100.005
Sino Grandness0.046-0.001
Straco Corp.0.760-0.015
Sunningdale Tech1.4000.020
Sunpower Group0.480-0.010
The Trendlines0.080-
Tiong Seng0.245-
Uni-Asia Group0.745-0.005
XMH Holdings0.153-
Yangzijiang Shipbldg1.500-0.020

NextInsight RSS

rss_2 NextInsight - Latest News

Online Now

We have 2119 guests and no members online